AU2024904192A0 - (O-acyl)-hydroxy fatty acid formulations for treatment of the eye - Google Patents

(O-acyl)-hydroxy fatty acid formulations for treatment of the eye

Info

Publication number
AU2024904192A0
AU2024904192A0 AU2024904192A AU2024904192A AU2024904192A0 AU 2024904192 A0 AU2024904192 A0 AU 2024904192A0 AU 2024904192 A AU2024904192 A AU 2024904192A AU 2024904192 A AU2024904192 A AU 2024904192A AU 2024904192 A0 AU2024904192 A0 AU 2024904192A0
Authority
AU
Australia
Prior art keywords
acyl
eye
treatment
fatty acid
hydroxy fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024904192A
Inventor
Furqan MAULVI
Mark Willcox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NewSouth Innovations Pty Ltd
Original Assignee
NewSouth Innovations Pty Ltd
Filing date
Publication date
Application filed by NewSouth Innovations Pty Ltd filed Critical NewSouth Innovations Pty Ltd
Publication of AU2024904192A0 publication Critical patent/AU2024904192A0/en
Pending legal-status Critical Current

Links

AU2024904192A 2024-12-18 (O-acyl)-hydroxy fatty acid formulations for treatment of the eye Pending AU2024904192A0 (en)

Publications (1)

Publication Number Publication Date
AU2024904192A0 true AU2024904192A0 (en) 2025-01-09

Family

ID=

Similar Documents

Publication Publication Date Title
WO2003013497A1 (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
WO2009091538A3 (en) Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia
RU2543720C2 (en) Compositions for treating inflammation and method of treating inflammation
HUP0303881A3 (en) Pharmaceutical compositions containing fatty alcohols and fatty acid esters useful for treatment of inflammation
EP4100406A4 (en) Compositions for treatment of ocular diseases
MY207295A (en) Method for preparing a composition comprising cetylated fatty acids
AU2024904192A0 (en) (O-acyl)-hydroxy fatty acid formulations for treatment of the eye
RU2705991C2 (en) Use of thia oxo compounds for lowering apo c3 content
ZA202207542B (en) Fatty acid composition for adjuvant treatment of essential tremor and preparation method therefor
AU2024904188A0 (en) Lipid formulations for treatment of the eye
AU2024900656A0 (en) Compositions and methods for the treatment of dermal disease
EP4320978A4 (en) Enhancement of message 3 for rach procedure
AU2024900544A0 (en) Composition for the treatment of skin conditions such as eczema
AU2025902002A0 (en) Compositions and methods for the treatment of oesophageal disorders
HK40126024A (en) Compositions for the treatment of cftr-mediated diseases
AU2025901970A0 (en) Implants for the prolonged release of active agents
AU2024901481A0 (en) Implants for the prolonged release of active agents
AU2024903392A0 (en) Agents for treatment of optic conditions
HK40117956A (en) Novel analogs of valproic acid and methods of medical treatment using the same
HK40085518A (en) Compositions for treatment of ocular diseases
AU2024900542A0 (en) Composition and method for the treatment of selected dermatological conditions
HK40118278A (en) Compositions and methods for treatment of thyroid eye disease
HK40117748A (en) Compositions and methods for treatment of thyroid eye disease
HK40092769A (en) Compositions and methods for the treatment of ocular diseases
AU2024904254A0 (en) Methods of treatment using vaccine compositions